This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Discover valuable tips for beginners in zero based budgeting. These insights will help you create a smart and effective budget plan.
16,186 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Behind every AI breakthrough lies a power backstop. This article explains how Vertiv quietly powering every AI data c...
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
SkyWater Technology just posted a record revenue figure, but the CFO sold about $2.5 million worth of stock. This art...
Ownli extends its commission-free home listing platform to 43 states as of March 1, 2026, showcasing a data-driven al...
Geopolitical risk in the Middle East adds new headwinds for Nvidia, threatening its Taiwan-based chip supply chain an...
As AI reshapes every industry, a few standout names sit beneath the radar. This guide flags the best stocks wall stre...
Investors noticed a notable move in jumia technologies stock jumped this week as Jumia reported improving early resul...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
The fear of a fixed 'there will permanent underclass' is common as AI reshapes work. This article debunks that myth a...
U.S. investors are watching three dividend aristocrats abroad as currency moves and energy swings threaten steady inc...
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...